Arden Trust CO Arrowhead Pharmaceuticals, Inc. Transaction History

Arden Trust CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$61.35 - $90.47 $258,344 - $380,969	-4,211 Closed	0 $0
Q4 2020 Jan 15, 2021	SELL	$43.82 - $85.37 $37,860 - $73,759	-864 Reduced 17.02%	4,211 $324,000
Q3 2020 Oct 15, 2020	SELL	$33.21 - $51.27 $62,069 - $95,823	-1,869 Reduced 26.92%	5,075 $218,000
Q1 2020 Apr 16, 2020	SELL	$20.56 - $63.12 $2,981 - $9,152	-145 Reduced 2.05%	6,944 $200,000
Q4 2019 Jan 17, 2020	SELL	$28.14 - $73.01 $1,575 - $4,088	-56 Reduced 0.78%	7,089 $450,000
Q3 2019 Oct 09, 2019	BUY	$26.26 - $34.86 $187,627 - $249,074	7,145 New	7,145 $201,000

295

92.3M

1.33M

549K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Arden Trust CO, based on Form 13F filings with the SEC.

Stay updated on Arden Trust CO with notifications on news.